Indivior Pharmaceuticals (INDV) Income from Continuing Operations (2024 - 2026)
Indivior Pharmaceuticals (INDV) recorded Income from Continuing Operations of $122 million in Q2 2026, up 577.8% from $18 million a year earlier and up 37.1% from the prior quarter.
Powered by 
Analysis
Indivior Pharmaceuticals (INDV) Income from Continuing Operations (2024 - 2026) Analysis & Trends
On a TTM basis, Indivior Pharmaceuticals' Income from Continuing Operations came in at $355 million as of Jun 30, 2026, up 225.7% year-over-year; for FY2025, it was $210 million.
- Annual Income from Continuing Operations has a four-year compound annual growth rate of 0.6% (FY2021 to FY2025).
- Across earlier years, Income from Continuing Operations came in at $7 million in FY2024, -$126 million in FY2023, -$43 million in FY2022 and $205 million in FY2021.
- The Q2 2026 figure is the highest quarterly Income from Continuing Operations in data going back to Q1 2024.
- On a year-over-year basis, Income from Continuing Operations has increased for four consecutive quarters, with growth averaging 223.4% over the last five quarters.
- Per Business Quant, the preceding three quarters came in at $89 million (Q1 2026), $102 million (Q4 2025) and $42 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -246.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Indivior Pharmaceuticals | 4.23 Bn | 3.19 Bn | 294.00 Mn | 122.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 122.00 Mn |
| Mar 31, 2026 | 89.00 Mn |
| Dec 31, 2025 | 102.00 Mn |
| Sep 30, 2025 | 42.00 Mn |
| Jun 30, 2025 | 18.00 Mn |
| Mar 31, 2025 | 48.00 Mn |
| Dec 31, 2024 | 21.00 Mn |
| Sep 30, 2024 | 22.00 Mn |
| Jun 30, 2024 | -98.00 Mn |
| Mar 31, 2024 | 62.00 Mn |
API Access
Indivior Pharmaceuticals Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();